Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

ClinicalTrials.gov ID: NCT04157686

Public ClinicalTrials.gov record NCT04157686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 3:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the long-term safety of MT10109L in the treatment of GL and/or LCL in participants with moderate to severe GL and/or LCL.

Study identification

NCT ID
NCT04157686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medy-Tox
Industry
Enrollment
957 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 22, 2019
Primary completion
Feb 15, 2023
Completion
Feb 15, 2023
Last update posted
Aug 8, 2024

2019 – 2023

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Clear Dermatology & Aesthetics Center Scottsdale Arizona 85255-4134
The Eye Research Foundation Newport Beach California 92663-3637
Art of Skin MD Solana Beach California 92075-2228
Susan H. Weinkle Bradenton Florida 34209-5642
Skin Research Institute Coral Gables Florida 33146-1837
Coleman Center For Cosmetic Dermatologic Surgery Metairie Louisiana 70006
Etre Cosmetic Dermatology and Laser Center New Orleans Louisiana 70130-4353
MD Laser Skin & Vein Hunt Valley Maryland 21030
Laser & Skin Surgery Center of New York New York New York 10016-4974
Skin Search of Rochester Inc. Rochester New York 14623
M3 Wake Research Inc. Raleigh North Carolina 27612-8106
Wilmington Dermatology Center Wilmington North Carolina 28403
Aventiv Research Dublin Dublin Ohio 43016
Westlake Dermatology & Cosmetic Surgery - Westlake Austin Texas 78746-4720
DermResearch Inc. Austin Texas 78759
Bellaire Dermatology Bellaire Texas 77401
SkinDC Arlington Virginia 22209
Virginia Clinical Research, Inc. Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04157686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2024 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04157686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →